Strides Pharma Inc has recalled Children's Ibuprofen Oral Suspension (NDC 51672-5321-8) following customer complaints about a gel-like mass and black particles found in the medication. The Class II recall designation indicates temporary or reversible health consequences are possible if the contaminated product is consumed. The recall is currently ongoing with nationwide U.S. distribution.

Pharmaceutical manufacturers and distributors should immediately halt distribution of the affected product and verify their inventory. Retailers and pharmacies must remove the recalled bottles from shelves and notify consumers who may have purchased this specific NDC. Healthcare providers should advise patients to return the product to place of purchase and seek alternatives. The FDA openFDA Enforcement API provides the official case record for this recall.